Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for BioPlus Co., Ltd. (099430:KRX), powered by AI.
BioPlus Co., Ltd. is currently trading at ₩4,580. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for BioPlus Co., Ltd. on Alpha Lenz.
BioPlus Co., Ltd.'s P/E ratio is 18.8.
“BioPlus Co., Ltd. trades at a P/E of 18.8 (fair value) with solid ROE of 9.7%. 3Y revenue CAGR of 17.0% highlights clear growth momentum.”
Ask for details →BioPlus Co., Ltd. specializes in the production and distribution of biopolymer-based aesthetic and therapeutic products. As a company operating at the forefront of biotechnology, its primary focus is on developing dermal fillers and absorbable barrier membranes primarily used in cosmetic and medical procedures. BioPlus Co., Ltd. significantly impacts the cosmetic and healthcare sectors by providing innovative solutions that enhance skin aesthetics and facilitate postoperative recovery. The company integrates cutting-edge technology and research to drive advancements in biopolymer applications, ensuring safety and efficacy for end-users. Established as a key player in the life sciences industry, BioPlus Co., Ltd. continues to contribute to the growing demand for non-surgical cosmetic enhancements and medical products, cementing its role within the rapidly evolving biotechnology market.
“BioPlus Co., Ltd. trades at a P/E of 18.8 (fair value) with solid ROE of 9.7%. 3Y revenue CAGR of 17.0% highlights clear growth momentum.”
Ask for details →BioPlus Co., Ltd. (ticker: 099430) is a company listed on KRX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 121 employees. Market cap is $282.3B.
The current price is ₩4,580 with a P/E ratio of 18.82x and P/B of 1.61x.
ROE is 9.73% and operating margin is 16.51%. Annual revenue is $90.9B.